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Background: Schizophrenia patients with auditory verbal hallucinations (AVH) have reduced structural integrity
in the left arcuate fasciculus (AFL) compared to healthy controls. However, it is neither known whether these
changes are speciﬁc to AVH, as opposed to hallucinations or schizophrenia per se, nor how radial and/or axial dif-
fusivity are altered. This study aimed to test the hypothesis that reductions to the structural integrity of the AFL
are speciﬁcally associated with AVH in schizophrenia.
Method: Diffusion tensor imaging scans and clinical data were obtained from the Australian Schizophrenia
Research Bank for 39 schizophrenia patients with lifetime AVH (18 current, 21 remitted), 74 schizophrenia pa-
tients with no lifetime AVH (40 with lifetime hallucinations in other modalities, 34 no lifetime hallucinations)
and 40 healthy controls.
Results: Fractional anisotropywas signiﬁcantly reduced in the AFL of patientswith lifetimeAVHcompared to both
healthy controls (Cohen's d=1.24) and patientswithout lifetimeAVH (d= .72), including compared to the spe-
ciﬁc subsets of patients without AVHwho either had hallucinations in othermodalities (d= .69) or no history of
any hallucinations (d= .73). Radial, but not axial, diffusivity was signiﬁcantly increased in patients with lifetime
AVH compared to both healthy controls (d = .89) and patients without lifetime AVH (d = .39). Evidence was
found for a non-linear relation between fractional anisotropy in the AFL and state AVH.
Conclusion: Reduced integrity of the AFL is speciﬁcally associated with AVH, as opposed to schizophrenia in gen-
eral or hallucinations in other modalities. Increased radial diffusivity suggests dysmyelination or demyelination
of the AFL may play a role in AVH.© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Auditory verbal hallucinations (AVH) are proposed to result from
altered connectivity between frontal and temporal left hemisphere lan-
guage regions (Feinberg, 1978; Frith, 1992; Ford et al., 2007; Whitford
et al., 2010). A key white matter tract linking these regions is the left
arcuate fasciculus (AFL), which connects the inferior frontal lobe, includ-
ing Broca's area, to the posterior superior temporal lobe, including
Wernicke's area (Catani et al., 2007). Diffusion tensor imaging (DTI)
has examined whether structural alterations to the AFL are associated
with AVH. The most commonly employed measure in DTI is Fractional
Anisotropy (FA), an index of the structural integrity of white matter ﬁ-
bres, with lower FA indicating reduced integrity.
A recent meta-analysis by Geoffroy et al. (2014) found reduced FA
in the AFL (henceforth FA-AFL) of schizophrenia patients with AVH,
compared to healthy controls. Because such comparisons cannot61 2 9850 6059.
rthy-Jones).
. This is an open access article underdemonstrate speciﬁcity of changes to AVH, which could instead be
due to schizophrenia per se, the authors recommended more studies
comparing patients with and without AVH. The only two studies to do
this (Catani et al., 2011, 28 ﬁrst-episode psychosis patients with AVH,
18 without; Benetti et al., 2015, 17 chronic schizophrenia patients
with AVH, 11 without) both failed to ﬁnd signiﬁcant differences. How-
ever, they only had sufﬁcient power to detect large effect sizes, poten-
tially causing Type II errors. For example, Benetti et al.'s data shows an
FA-AFL reduction in the AVH group of a medium effect size. The ﬁrst
aim of our study was to test the hypothesis that FA-AFL is lower in pa-
tients with schizophrenia with AVH, compared to both patients with
schizophrenia without AVH, and healthy controls, in a study powered
to detect medium effect sizes.
A second recommendation of Geoffroy et al. (2014) was that DTI
studies of AVH should report on radial diffusivity and axial diffusivity,
as these are associated with speciﬁc biological changes. Increased radial
diffusivity is associatedwith reducedmyelination (Song et al., 2005), re-
duced axial diffusivity with axonal damage (Song et al., 2003), although
caution is needed in such interpretations in the absence of post-mortemthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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axial diffusivity has been found to be higher in schizophrenia patients
with AVH compared to healthy controls (de Weijer et al., 2011), yet
schizophrenia patients with AVH have also been found to have higher
radial diffusivity than non-psychiatric patients with AVH, suggesting a
lack of speciﬁcity to AVH (de Weijer et al., 2013). The second aim of
our study was hence to test the hypothesis that schizophrenia patients
with AVH have higher radial (but not axial) diffusivity than both
patients without AVH, and healthy controls.
We also aimed to undertake more exploratory analyses. First, given
the role of the AFL in language (Catani et al., 2005), we hypothesised de-
creases in FA-AFL in patients with AVH compared to patients with hallu-
cinations restricted to other modalities (e.g., visual hallucinations).
Second, as some previous studies have employed patients with both
current and remitted AVH (e.g., Benetti et al., 2015), we aimed to test
whether FA-AFL changes associated with AVH reﬂected a state or trait
phenomena. Finally, we aimed to undertake the ﬁrst empirical test
based on the proposal that if AVH represent the brain's attempt to incor-
porate disjointed neural activity then this integration may only be pos-
sible up to a certain level of temporal desynchronisation (Whitford
et al., 2010). Whilst intermediate asynchronies could result in AVH, se-
vere asynchronies may not be able to be incorporated into a coherent
auditory experience, thus not giving rise to AVH, andmild asynchronies
may integratable into the ﬂow of normal experience (Whitford et al.,
2010). We hence aimed to test the hypothesis that, within schizophre-
nia patients, changes in FA-AFL relative to healthy controls would have
a non-linear (quadratic) relationship to the probability of current AVH.
2. Method
2.1. Sample size
GPower v3.1.9 (Faul et al., 2007) indicated 102 patients were re-
quired to detect a medium effect size (Cohen's d = .50) when compar-
ing patients with and without lifetime AVH (β= .80, one-tailed test,
α = .05). To allow testing of our exploratory hypotheses, we aimed
for a ratio of two patientswithout lifetimeAVH (onewith hallucinations
but not AVH, and one with no hallucinations in any modality) to eachTable 1
Descriptive statistics.
SZ:AVH+(n = 39) SZ:AVH−
Demographics
Age/years (mean, SD) 39.36 (10.53) 39.05 (9.3
Gender (% male) 82% 81%
Handedness (% right) 92% 92%
IQ (mean, SD) 100.36 (16.41) 103.50 (1
Drugs
Antipsychotic use/months (mean, SD) 48.28 (38.68) 48.16 (33
Substance use (%) 72% 63%c
Alcohol abuse/dependence (%) 32%a 46%d
Psychopathology
Duration of illness (years) 15.67 (8.98) 14.57 (8.8
Depression (mean, SD) .31 (1.15) .42 (1.52)
Delusions (%) 38% 48%c
Negative formal thought disorder (%) 29%a 37%c







Note. SZ:AVH+= Schizophrenia with lifetime auditory verbal hallucinations. SZ:AVH−= Sc
a n = 38 due to missing data.
b n = 68 due to missing data.
c n = 73 due to missing data.
d n = 69 due to missing data.patient with lifetime AVH. Recalculating the necessary sample size
using an allocation ratio of .5, indicated that an AVH groupwas required
of 38 people, and a non-AVH group of 76 people.
2.2. Participants
Data on patients with DSM-IV schizophrenia diagnoses were obtain-
ed from the Australian Schizophrenia Research Bank (ASRB; Loughland
et al., 2010). Clinical and diagnostic information had been obtained by
trained research staff using the Diagnostic Interview for Psychosis
(DIP; Castle et al., 2006). Exclusion criteria included an inability to
converse ﬂuently in English, organic brain disorder, brain injury with
post-traumatic amnesia N24 h, intellectual disability (IQ b 70), current
diagnosis of substance dependence, and electroconvulsive therapy
received in the last 6 months.
Thirty-nine patients (SZ:AVH+)had a lifetime history of AVH, oper-
ationalized as a non-zero total score on lifetime ratings of DIP items #51
(Accusatory/abusive/persecutory voices), #52 (Running commentary)
and#53 (Third person auditory hallucinations). Of these, 18 had current
AVH (last occurrence b 1 month ago) and 21 had remitted AVH (last
occurrence N 1month ago). Seventy four patients (SZ:AVH−) were de-
ﬁned as having no lifetime history of AVH or non-verbal auditory hallu-
cinations, as operationalized by a zero score on the lifetime rating of DIP
items #50 (non-verbal auditory hallucinations), #51, #52 and #53. This
group comprised of two subgroups; 34 patients with no lifetime history
of any hallucinations (henceforth SZ:H−), operationalized by a zero
score on the lifetime rating of DIP item #49 (hallucinations in any
modality), and 40 patients with lifetime hallucinations but none in the
auditory verbal modality (henceforth SZ:H+/AVH−), operationalized
as a non-score on the lifetime rating of DIP item #49, but a zero score
on the lifetime ratings of DIP items #51–53.
Duration of use of antipsychotic medication was taken from ASRB
records, and was available for 107 of the 113 patients (Table 1). The
upper limit of classiﬁcation recorded by the ASRB was N8 years. This
hence underestimated usage. The presence of delusions was deﬁned
as a non-zero score on the sum of present state (previous month)
ratings on the delusions section of the DIP (items #58–64). Negative
symptoms were assessed using lifetime ratings (current state not(n = 74) Healthy controls (n = 40) Group difference
5) 39.03 (10.28) F(2,150) = .02, P= .99
83% χ2(2) = .04, P= .98
93% χ2(2) = .02, P= .99
4.50) 119.63 (8.77) F(2,150) = 23.63, P b .001
.65)b – t(105) = .02, P= .99
– χ2(1) = .87, P= .35
– χ2(1) = 2.22, P= .14
0) – t(111) = .63, P= .53
– t(111) = .40, P= .69
– χ2(1) = .93, P= .34
– χ2(1) = .87, P= .65
– χ2(1) = .16, P= .69
15
8
8 χ2(8) = 13.28, P= .10
8
1
hizophrenia with no lifetime auditory verbal hallucinations. SD = standard deviation.
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#88 (catatonia). Lifetime presence of substance use and alcohol
abuse/dependence was assessed using DIP items #72 and #74 re-
spectively. Depression was calculated as the sum of present state
(previous month) ratings of DIP items #20–22, creating total scores
(Cronbach's α= .75) ranging from 0–9, with higher scores indicating
greater levels of depression.
Forty healthy controls had been screened for a family history of, or
treatment for, psychiatric illness, and did not have had a history of
epilepsy, seizures, dementia, neurological illnesses, movement disor-
ders, organic brain disorders, brain injury or head injury with post-
traumatic amnesia N24 h.
2.3. Image acquisition
Diffusion-weighed images (DWIs)were acquired from identical 1.5T
Siemens Avanto scanners (Siemens, Erlangen, Germany) from ﬁve dif-
ferent Australian locations. Imaging parameters were identical across
scanners: 65 axial slices enabling whole-brain coverage were acquired
in 64 diffusion directions with b = 900 s/mm2. One baseline scan with
b = 0 was also acquired. The scan parameters were: TR 8400 ms, TE
88 ms, FOV 25 cm, 104 × 104 matrix, 2.4 mm slice thickness without
gap, producing isotropic 2.4 mm voxels. Total scanning time was
approximately 9 min.
2.4. Extraction of the arcuate fasciculus
The AFL was extracted from DT images using deterministic
tractography (as per Whitford et al., 2011) and implemented in the
Slicer-3 software package (version 4.2.0, nightly build, www.slicer.
org). A cubic region of interest (i.e. a ﬁducial) of side 2.50 mm was
manually placed in the dorsal longitudinal ﬁbres of the AFL. The voxels
deﬁned by this ﬁducial were used as seedpoints for deterministic
(streamline) tractography, which followed the direction deﬁned by
the principal eigenvector. A step size of 1.00 mm was used, and
tractography was terminated upon reaching a voxel of FA b 0.25 (the
stopping criterion). Minimum/maximum path lengths were 20.00/
800.00mm,with an integration step length of 0.50mm. The small num-
ber of voxels deﬁned by the ﬁducial meant real-time feedback was
available on the accuracy of the ﬁducial's location. Its spatial position
was then adjusted until distinctive ventrally projecting, curved ﬁbres
of theAFL becameapparent. Once theﬁbres had been extracted, a binary
label map was generated for each participant by labelling those voxels
through which any ﬁbres passed. Fig. 1 shows a sample AFL. These
u-shaped ﬁbres represent what Catani et al. (2011) term the “long
direct segment” of the AFL, i.e., we were not assessing its anterior
and posterior indirect segments.
FA was calculated for every voxel in each subject's label map. The
mean FA of all voxels deﬁned by the label map was calculated for each
subject, and used in the statistical analysis. All tractography was per-
formed by a single rater (L.O.), blind to participant group. Intra-rater
reliability was assessed through the recalculation of FA for 10 partici-
pants using a different nightly build of Slicer. These recalculated values
correlated signiﬁcantly with the original values, r = .95, P b .001.
2.5. Statistical analysis
Group differences were tested using analysis of variance (ANOVA),
with signiﬁcant group effects being followed by 1000 bootstrapped
sample t-tests. As recommended by Bender and Lange (2001), where
conﬁrmatory analyses were undertaken (i.e., conﬁrming FA was lower
in patients with AVH compared to healthy controls), Bonferroni correc-
tions to alpha were used. Where t-tests were performed to test direc-
tional hypotheses, one-tailed tests were employed. For exploratory
analyses, due to Type II errors being deemed more problematic than
Type I errors, and due to the already reduced power of the subgroupanalyses, we did not adjust signiﬁcance levels for post-hoc tests
(Perneger, 1998; Bender and Lange, 2001).
3. Results
The three study groups were matched on age, gender, and handed-
ness (Table 1). There were no signiﬁcant differences between the pro-
portion of participants scanned at each location (Table 1). The two
schizophrenia groups were matched on duration of antipsychotic
usage, duration of illness, severity of illness (via symptom ratings) and
alcohol and substance use (Table 1). When screening diffusivity data,
outliers were deﬁned as scores N3SD from themean (Field, 2007), lead-
ing to the exclusion of axial diffusivity scores of three participants (two
SZ:AVH−, one HC).
3.1. Primary analyses
Groupmeans are presented in Table 2, and illustrated graphically in
Fig. 2. ANOVA revealed an effect of group (SZ:AVH+, SZ:AVH−, HC) on
FA-AFL (F2,150 = 13.33, P b .001, partial η2 = .15). Two planned t-tests
(Bonferroni corrected alpha = .025) tested our speciﬁc directional hy-
pothesis. The SZ:AVH+ group had signiﬁcantly lower FA-AFL than
both the SZ:AVH− groups, P(one-tailed) b .001, d = .72, and the
healthy control group, P(one-tailed) b .001, d = 1.24. Two further
ANOVAs found an effect of group on radial (F2,150 = 7.11, P= .001, par-
tial η2 = .09), but not axial (F2,147= 2.10, P= .13, partial η2 = .03) dif-
fusivity. Two planned t-tests (Bonferroni corrected alpha= .025) tested
our speciﬁc directional hypothesis, ﬁnding that radial diffusivity was
signiﬁcantly higher in the SZ:AVH+ group than both the SZ:AVH−,
P(one-tailed) = .024, d = .39, and healthy control group, P(one-
tailed) b .001, d = .89. (See Fig. 3.)
3.2. Exploratory analyses
3.2.1. Speciﬁcity to AVH
ANOVA found an effect of group on FA-AFL, after repeating the above
analyses but splitting the SZ:AVH− group into its two sub-groups: SZ:
H+/AVH− and SZ:H− (F3,149 = 8.87, P b .001, partial η2 = .15;
Table 2). Two planned t-tests tested our directional hypotheses, and
found the SZ:AVH+ group had signiﬁcantly lower FA-AFL than both
the SZ:H+/AVH− groups, P(one-tailed) = .002, d = .69, and the SZ:
H− group, P(one-tailed) = .001, d = .73. ANOVA found an effect of
group on radial diffusivity (F3,149 = 4.87, P = .003, partial η2 = .09),
with two planned t-tests ﬁnding that the SZ:AVH+ group had higher
radial diffusivity than the SZ:H+/AVH− group, P(one-tailed) = .02,
d = .46, but did not differ from the SZ:H− group, P(one-tailed) = .09,
d = .31. ANOVA also found an effect of group on axial diffusivity
(F3,146 = 2.74, P = .05, partial η2 = .05), with two planned t-tests
ﬁnding that SZ:AVH+ had lower axial diffusivity than the SZ:H−
group, P(two-tailed) = .008, d = .65, but not the SZ:AVH−/H+
group, P(two-tailed) = .43, d = .17.
3.2.2. State and trait
ANOVA examined the effect of group on FA-AFL, after splitting the
SZ:AVH+ group into two sub-groups: SZ:AVH+(current) and SZ:
AVH+(remitted), but retaining a single SZ:AVH− group (Table 2).
There was an effect of group on FA-AFL (F3,149 = 9.85, P b .001, partial
η2 = .17). Three planned t-tests found no difference between the SZ:
AVH+(current) and SZ:AVH+(remitted) groups, P(two-tailed) = .08,
d = .55, but found that both the SZ:AVH+(remitted) group, P(one-
tailed) b .001, d = .90, and the SZ:AVH+(current) group, P(one-
tailed) = .017, d = .49, had lower FA-AFL than the SZ:AVH− group.
3.2.3. Non-linear relations
The difference between each patient's FA-AFL and the mean FA-AFL
of healthy controls was calculated (henceforth ΔAFL). Binary logistic
Fig. 1. Sample of tracing of the left arcuate fasciculus.
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tient data only (n=113), with current experience of AVH as the depen-
dent variable (current AVH = 1, no current or lifetime AVH = 0) and
ΔAFL as the independent variable. This model was not a signiﬁcant pre-
dictor of the presence of AVH,χ2(1)= .72, P=.40, NagelkerkeR2= .01.
Binary logistic regression was then performed with the addition of a
quadratic term. ΔAFL was mean centred, and used to create linear andTable 2
Means and standard deviations for fractional anisotropy and diffusivity measures.
Measure Schizophrenia with lifetime AVH Schiz
Total group (n = 39) Current (n = 18) Remitted (n = 21) Total
FA (×102) 50.26 (2.54) 50.99 (1.99) 49.64 (2.82) 52.19
RD (×105) 51.40 (2.85) 51.11 (2.58) 51.66 (3.11) 50.25
AD (×104) 11.74 (.41) 11.86 (.37) 11.64 (.41) 11.90
FA= Fractional anisotropy. RD=Radial diffusivity. AD=Axial diffusivity. AVH=Auditory ver
the auditory verbal modality. SZ:H−= Schizophrenia with no lifetime hallucination.
a Two participants excluded as outliers (see text for deﬁnition of outlier).





. This model was a signiﬁcant predictor of current
AVH, χ2(2) = 7.49, P = .024, Nagelkerke R2 = .11, with only
ΔAFL−ΔAFL
 2
being a signiﬁcant predictor, P = .034. To illustrate
this, ΔAFL scores were divided into six blocks of equal interval, and the
proportion of patientswith current AVHwithin each blockwas calculat-
ed. As Table 3 shows, patients with a 1–9% decrease in FA-AFL, relative
to themean FA-AFL of healthy controls,weremost likely to currently ex-
perience AVH. Thosewith larger FA-AFL decreases or smaller decreases/
increases in FA-AFL were less likely to have current AVH.4. Discussion
DTI was used to examine if structural changes to the left arcuate fas-
ciculus (AFL) were speciﬁcally associated with AVH in patients with
schizophrenia. Patients with lifetime AVH had signiﬁcantly lower frac-
tional anisotropy in this tract (FA-AFL) than patients without lifetime
experience of AVH, with this difference representing a large effect size.
Patients with lifetime AVH had signiﬁcantly higher radial (but not
reduced axial) diffusivity in the AFL than patients without lifetime
experience of AVH. Although this could indicate that dysmyelination
or demyelination of this tract is associated with AVH (Song et al.,
2005), post-mortem study would have been necessary to conﬁrm this
(Wheeler-Kingshott and Cercignani, 2009).
Exploratory sub-analyses found patients with lifetime AVH had sig-
niﬁcantly lower FA-AFL than patients with hallucinations restricted to
othermodalities. This suggested speciﬁcity of FA-AFL reductions to audi-
tory verbal hallucinations, consistent with role of the AFL in language
(Catani et al., 2005). Inconsistent ﬁndings emerged from comparisons
of radial diffusivity and axial diffusivity between patients with lifetime
AVH and the two patient control groups (no history of hallucinations,
hallucinations in non-auditory verbal modalities). However, in the
case of radial diffusivity, non-signiﬁcant increases in the lifetime AVH
group compared to the two patient control groupswere in the expected
direction and were of a small–medium effect size, potentially suggest-
ing a Type II error. Better powered study is required.
Exploratory analyses found that both patients with current and
remitted AVH had lower FA-AFL than patients without AVH. This
suggested that remission of AVH is not associated with normalisation
of FA-AFL. A non-signiﬁcant trend of medium effect size was found
towards those with remitted AVH having lower FA-AFL than those
with current AVH. There was thus some evidence, in our underpowered
analyses, that remitted AVH were associated with the lowest FA-AFL,
and that those with current AVH had FA-AFL intermediate between re-
mitted AVH patients and patients who had never experienced AVH.
This is unexpected in a framework where AVH are understood to be
linearly associated with decreased AFL integrity. However, within non-
linear frameworks (Whitford et al., 2010), this becomes interpretable.
Speciﬁcally, AVHmay be encouraged by intermediate levels of integ-
rity reduction to the FA-AFL, with greater or smaller reductionsophrenia with no lifetime AVH Healthy controls
(n = 40)
group (n = 74) SZ:H+/AVH−(n = 40) SZ:H−(n = 34)
(2.84) 52.09 (2.75) 52.30 (3.00) 53.28 (2.31)
(3.00) 50.05 (2.98) 50.49 (3.06) 48.97 (2.60)
(.41)a 11.81 (.39)b 12.01 (.42)b 11.89 (.44)b
bal hallucination. SZ:H+/AVH−=Schizophrenia with lifetime hallucinations but none in
Fig. 2.Mean fractional anisotropy by group.
5S. McCarthy-Jones et al. / Schizophrenia Research 162 (2015) 1–6reducing the probability of AVH. Indeed, our preliminary ﬁnding of a
non-linear relation between FA-AFL alterations and current experi-
ences of AVH, offered the ﬁrst empirical evidence for this theory.
Yet the ﬁnding that patients with remitted AVH did not have FA-
AFL comparable to patients without AVH, or healthy controls, is puz-
zling in the context of previous suggestions that atypical antipsy-
chotics have their effects partly through improving myelin integrity
(Ren et al., 2013; Ozcelik-Eroglu et al., 2014). Better powered stud-
ies, as well as the examination of longitudinal relations between
FA-AFL and AVH, are needed.
This study had a number of limitations. First, although data was
available on duration of antipsychotic usage, dosage was not available
and confounding by differences in medication exposure cannot be
fully excluded. Second, recruiting such a precisely deﬁned sample
meant that it was necessary to use data from ﬁve sites. Whilst allFig. 3.Mean radial diffusivity anscanners were built to identical speciﬁcations, the possibility that in-
homogeneities between scanners could have affected DTI metrics can-
not be eliminated. Third, our exploratory analyses were underpowered.
Fourth, our lack of corrections to alpha, although increasing the power
of our analyses, also increased the risk of Type I errors. Fifth, post-
mortem studies of white matter pathways are needed, in addition to
in vivo studies, to determine the histological correlates of altered anisot-
ropy (Highley et al., 2002). Finally, we focussed speciﬁcally on
intrahemispheric connectivity within the AFL, but altered interhemi-
spheric connectivity (cf. Crow, 1997, 2010) such as between left and
right primary and secondary auditory cortices, may also play a role in
AVH (Gavrilsecu et al., 2010). Future studies may wish to consider
how both intra- and inter-hemispheric changes to structural and func-
tional connectivity may individually and/or additively contribute to
AVH formation.d axial diffusivity by group.
Table 3
Probability of patients having current AVH by size/direction of structural integrity change relative to healthy controls.
% Change in fractional anisotropy in the left arcuate fasciculus (FA-AFL) relative to mean FA-AFL of healthy controls
−17.8% to−13.6% −13.5% to−9.4% −9.3% to−5.1% −5.0% to−0.9% −0.8% to +3.3% +3.4% to +7.6%
Number of patients 2 16 24 30 26 15
Percentage with current AVH 0% 13% 21% 27% 12% 0%
AVH = Auditory verbal hallucinations.
6 S. McCarthy-Jones et al. / Schizophrenia Research 162 (2015) 1–6In conclusion, this study offers the ﬁrst clear evidence of FA-AFL re-
ductions being speciﬁcity attributable to auditory verbal hallucinations,
rather than hallucinations or schizophrenia per se. Although it also pro-
vides evidence consistent with these changes speciﬁcally reﬂecting re-
duced myelination of the AFL, it remains unclear if such changes result
from dysmyelination, a failure of myelination during development
(Crow et al., 2007), or a process of demyelination similar to that found
in multiple sclerosis. Both this question and the potential for a non-
linear relation to exist between FA-AFL and state AVH, require further
study.
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